- Home
- BCIC vs ATRA Comparison
BCIC vs ATRA Comparison
Compare BCIC & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCIC | ATRA |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.6M | 94.2M |
| IPO Year | 2006 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BCIC | ATRA |
|---|---|---|
| Price | $5.97 | $9.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $9.83 | ★ $13.67 |
| AVG Volume (30 Days) | ★ 32.3K | 28.1K |
| Earning Date | 11-05-2026 | 11-11-2026 |
| Dividend Yield | ★ 17.68% | N/A |
| EPS Growth | ★ 262.50 | 122.52 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $120,772,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1,334.59 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.33 | $3.92 |
| 52 Week High | $13.50 | $19.15 |
Technical Indicators
Market Signals| Indicator | BCIC | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 19.05 | 52.13 |
| Support Level | N/A | $8.94 |
| Resistance Level | $7.57 | $9.93 |
| Average True Range (ATR) | 0.18 | 0.61 |
| MACD | -0.07 | 0.00 |
| Stochastic Oscillator | 0.87 | 64.37 |
Price Performance
Historical ComparisonAbout BCIC BCP Investment Corporation
BCP Investment Corp is an externally managed, non-diversified closed-end investment company. The company invests in secured term loans, bonds or notes and mezzanine debt in privately-held middle market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt and selected equity investments in privately-held middle market companies.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.